Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants
Covid19-Sources
Inferring change points in the spread of COVID-19 reveals the effectiveness of interventions
Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis
Impacts of school closures on physical and mental health of children and young people: a systematic review
Transmission of SARS-CoV-2 in Norwegian schools: A population-wide register-based cohort study on characteristics of the index case and secondary attack rates
Jump seen in hospitalization of kids with post-COVID syndrome that killed teen
7-Tage-Wachstum der 7-Tage-Inzidenz | Created with Datawrapper
Meta-analysis of randomized trials of ivermectin to treat SARS-CoV-2 infection
Erste vorläufige Ergebnisse der Todesursachenstatistik für 2020 mit Daten zu COVID-19 und Suiziden
New paper out: Germany’s current COVID-19 crisis is mainly driven by the unvaccinated | Dirk Brockmann - Research on Complex Systems
Yuval Harpaz on Twitter
Covidrechner
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
Coronavirus-Karte für Deutschland: Coronavirus in Deutschland und bei Ihnen – alle Zahlen im Überblick
COVID Data Tracker
Immune Responses in Fully Vaccinated Individuals Following Breakthrough Infection with the SARS-CoV-2 Delta Variant in Provincetown, Massachusetts
(3) A Marm Kilpatrick auf Twitter: "How do we get broad immunity to SARS-CoV-2 that will protect against future variants? 2 studies (are there more?) suggest that vaccination followed by infection gives broader protection than infection followed by vaccination. @florian_krammer @profshanecrotty @GuptaR_lab https://t.co/rqdf6rE9ej" / Twitter
Interpreting COVID-19 deaths among nursing home residents in the US: The changing role of facility quality over time
Antibody titers measured by commercial assays are correlated with neutralizing antibody titers calibrated by international standards
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 | NEJM
Diagnosis value of SARS‐CoV‐2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission
Deplatform Disease
Bald kommt der Impfstoff für die Skeptiker
(2) Edward Nirenberg auf Twitter: "Because the N protein is *inside* the actual virus, antibodies directed against the N protein cannot target viral particles. It's thought that these antibodies occur because of the rupturing of infected cells leaking N protein where a B cell might find them and become activated." / Twitter
100 Prozent Impfquote und Inzidenz über 1.300: Das große Rätsel um Gibraltar | Welt
Wie lange schützt der Impfstoff von Biontech, Moderna, Astrazeneca? - Spektrum der Wissenschaft
(8) Eric Topol auf Twitter: "Side by side event curves for the original Pfizer vaccine trial vs the Booster trial You can see the curves diverge about a week earlier with a booster, ~14 vs 7 days, which aligns with much faster induction of neutralizing antibodies https://t.co/WhnZbjyIXj" / Twitter
COVID-19: Tetris auf der Intensivstation - DocCheck
Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study
Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum | NEJM